personalized medicine

Research in Review

Bloodstream Infections Increase Costs, Length of Stay for Pediatric Cancer and Transplant Patients

09/06/2016

JCP Editors

Pediatric oncology and stem cell transplant patients with ambulatory bloodstream infections have higher health care costs and unplanned extended hospital admissions, claims a recent study. ----- Related...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Novel ESC Position Paper Addresses Cardiotoxicity of Cancer Therapies

09/02/2016

JCP Editors

Advances in cancer treatment have improved the survival of patients, but have also increased morbidity and mortality due to treatment side effects. The effects of cancer treatments on the cardiovascular system are...

...

09/02/2016

Journal of Clinical Pathways

Research in Review

Immune Signatures Predict Treatment Response for Melanoma

09/01/2016

JCP Editors

Adaptive immune signatures in tumor biopsy samples obtained early during the course of treatment may be used to predict patient response to melanoma immunotherapy, according to a study published in Cancer...

...

09/01/2016

Journal of Clinical Pathways

Research in Review

Scan-associated Distress Common and Problematic Among Patients With NSCLC

08/25/2016

JCP Editors

Scan-associated distress, a common problem among patients with non-small cell lung cancer (NSCLC), may negatively affect quality of life, according to a study published in the journal Lung Cancer. Commonly referred...

...

08/25/2016

Journal of Clinical Pathways

Research in Review

Leptomeningeal Metastases More Common in EGFR+ Lung Cancer

08/17/2016

JCP Editors

Leptomeningeal metastases (LM) incidence is far more common in patients with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) mutations and is best treated with targeted tyrosine kinase...

...

08/17/2016

Journal of Clinical Pathways

Research in Review

Tumor Genetics Can Change During Treatment for ER+ Breast Cancer

08/12/2016

JCP Editors

Treating human estrogen-receptor (ER)-positive breast cancer tumors with estrogen-deprivation therapy can change the spectrum of mutations in the tumor population, affecting treatment response, according to research...

...

08/12/2016

Journal of Clinical Pathways

Research in Review

Systemic Therapy Use Growing Among Elderly Patients With Head and Neck Cancer

08/12/2016

JCP Editors

Despite conflicting prospective evidence, most elderly patients with locoregionally advanced head and neck cancer treated with definitive radiotherapy also receive systemic therapy, according to results from a study...

...

08/12/2016

Journal of Clinical Pathways

Research in Review

Active Surveillance Feasible for Some Patients With Kidney Cancer

08/10/2016

JCP Editors

Certain patients with metastatic renal cell carcinoma can (RCC) safely undergo active surveillance before initiating systemic treatment, findings from a study published in The Lancet Oncology show. RCC has a wide...

...

08/10/2016

Journal of Clinical Pathways

Research in Review

Equivalent Outcomes With Two NSCLC Treatment Options

08/04/2016

JCP Editors

Erlotinib may be an effective therapeutic option for patients with pretreated advanced non-small cell lung cancer (NSCLC) and no known molecular alterations, according to a study published in the journal Lung...

...

08/04/2016

Journal of Clinical Pathways

Research in Review

Radiotherapy Use and Effectiveness in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

08/02/2016

JCP Editors

A study of adjuvant chemoradiotherapy (CRT) and boost doses of postoperative radiotherapy (B-PORT) in oropharyngeal squamous cell carcinoma (OSCC) has found that outcomes depend on a number of pathologic and...

...

08/02/2016

Journal of Clinical Pathways